2018
The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Abstract: Purpose: Netarsudil, an inhibitor of Rho kinase and a norepinephrine transporter, has been shown to lower elevated intraocular pressure (IOP) in controlled studies of patients with open-angle glaucoma and ocular hypertension, and in healthy volunteers. The mechanism of this ocular hypotensive effect in humans is unknown.Methods: The objective of this study was to evaluate the effect of netarsudil 0.02% on aqueous humor dynamics (AHD) parameters. In this double-masked, vehicle-controlled, paired-eye comparison …
Search citation statements
Paper Sections
Select...
84
24
21
3
Citation Types
1
106
0
3
Year Published
Range
2001
2026
Publication Types
Select...
102
11
3
1
Relationship
14
103
Authors
Journals
Cited by 117 publications
(110 citation statements)
References 37 publications
1
106
0
3
Smart CitationsHow the paper below cites the one you are viewing
“…This is similar to the results of our previous study of healthy human subjects, which found a mean decrease in EVP of 10% compared to baseline in the netarsudil-treated group. 33 This is not surprising given that baseline EVP values in both studies were similar (7.9 mm Hg in healthy human subjects vs. 7.7 mm Hg in our current study of POAG/OHT patients). However, as with outflow facility, the effect of netarsudil on EVP appears to be species-dependent.…”
Section: Discussion
supporting
confidence: 67%
Netarsudil Improves Trabecular Outflow Facility in Patients with Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 2 Study
American Journal of Ophthalmology
Self Cite
Abstract